Showing results (2111-2120 of 2,534) with videos related to
Sort By:
Pageof 254
The Medical Journal of Australia|July 24, 2025
The epidemiology of haemodialysis catheter infections in Australia, 2016-20: a prospective cohort studyBenjamin Lazarus, Kevan R Polkinghorne, Martin P Gallagher, et al.BMC Surgery|October 8, 2025
Comparative outcomes of synthetic and biological mesh use in laparoscopic inguinal hernia repair: a systematic review and meta-analysisCandela Romano, Hugo Silva, Laura A Gray, et al.School Psychology (Washington, D.C.)|February 10, 2025
Understanding adolescent mental health symptom progression in school-based settings: The Substance Use and Risk Factors (SURF) longitudinal surveyMeghan A Costello, Michael Pascale, Kevin Potter, et al.Neurology|December 11, 2002
Fluctuations in attention: PD dementia vs DLB with parkinsonismC G Ballard, D Aarsland, I McKeith, et al.Neuroimage|July 26, 2003
Cognitive effects of nicotine in humans: an fMRI studyVeena Kumari, Jeffrey A Gray, Dominic H ffytche, et al.Neuroimage. Clinical|November 2, 2013
Abnormalities in fronto-striatal connectivity within language networks relate to differences in grey-matter heterogeneity in Asperger syndromeEugenia Radulescu, Ludovico Minati, Balaji Ganeshan, et al.Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 16, 2017
Intravascular Ultrasound Validation of Contemporary Angiographic Scores Evaluating the Severity of Calcification in Peripheral ArteriesDa Yin, Akiko Maehara, Thomas M Shimshak, et al.FEMS Microbiology Ecology|May 19, 2011
Development of associations between microalgae and denitrifying bacteria in streams of contrasting anthropogenic influenceChristopher G Peterson, Allison D Daley, Shannon M Pechauer, et al.The Pharmacogenomics Journal|February 16, 2012
Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndromeE Radulescu, B Ganeshan, L Minati, et al.American Journal of Human Genetics|June 1, 1995
Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patientT L Alley, B A Gray, S H Lee, et al.Pageof 254